PATENT CLAIM ANALYSIS

Application Number: 16270837
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "494000"]

Abstract:
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 27):
The method of  claim 1 , wherein said dosage form provides a plasma concentration of ARBAC that is at least 4-fold higher than the cerebrospinal fluid concentration of ARBAC.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 99.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15146525', '15919422', '15048743', '15919436', '15132972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8618019669958885
- 35 USC 102 Novelty (BERT): 0.6411919089350473
- Combined Prediction Score: 0.8397409611898043
- Mean Citation Score: 576.303538
- Max Citation Score: 585.8544
- Similarity Product: 504.6135004285813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test